UFF
KRYS icon

USA FINANCIAL FORMULAS’s Krystal Biotech KRYS Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Buy
+269
New +$80.4K 0.02% 179

Other funds holding KRYS

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PIP
Palisades Investment Partners Santa Monica, California $352M AUM 76.79% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

USA FINANCIAL FORMULAS's KRYS Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Krystal Biotech (KRYS) in Q2 2026: 269 shares worth $100K. The stake represents 0.02% of the portfolio and ranks #179 among its holdings.

151 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • USA FINANCIAL FORMULAS held 269 shares of Krystal Biotech worth $100K as of Q2 2026.
  • Krystal Biotech was a new USA FINANCIAL FORMULAS position in Q2 2026.
  • Krystal Biotech made up 0.02% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #179 holding.
  • 151 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.